List of Excipients in API buprenorphine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing buprenorphine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Indivior Inc | SUBLOCADE | buprenorphine | 12496-0100 | METHYLPYRROLIDONE | |
| Indivior Inc | SUBLOCADE | buprenorphine | 12496-0100 | POLY(DL-LACTIC-CO-GLYCOLIC ACID) | |
| Rhodes Pharmaceuticals LP | BUPRENORPHINE | buprenorphine | 42858-750 | ETHYL LEVULINATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing buprenorphine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 | ANHYDROUS CITRIC ACID |
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 | CROSPOVIDONE |
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 | LACTOSE MONOHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for buprenorphine
Excipient focus: .ALPHA.-TOCOPHEROL
buprenorphine drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: .ALPHA.-TOCOPHEROL ACETATE
buprenorphine drug variants containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing .ALPHA.-TOCOPHEROL ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACESULFAME POTASSIUM
buprenorphine drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| SpecGx LLC | buprenorphine and naloxone | 0406-1923 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
buprenorphine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
buprenorphine drug variants containing ALUMINUM OXIDE
buprenorphine drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
buprenorphine drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Aveva Drug Delivery Systems Inc | buprenorphine and naloxone | 3215-6521 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
buprenorphine drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DEXTROSE
buprenorphine drug variants containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine hydrochloride | 0143-9246 |
| Hospira Inc | buprenorphine hydrochloride | 0409-2012 |
| Indivior Inc | buprenorphine hydrochloride | 12496-0757 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
buprenorphine drug variants containing ANHYDROUS LACTOSE
buprenorphine drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
buprenorphine drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYANISOLE
buprenorphine drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | buprenorphine | 50268-128 |
| Clinical Solutions Wholesale LLC | buprenorphine | 58118-0460 |
| Clinical Solutions Wholesale LLC | buprenorphine | 58118-4459 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
buprenorphine drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | buprenorphine and naloxone | 31722-479 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
buprenorphine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
buprenorphine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| Contract Pharmacy Services-PA | buprenorphine hydrochloride sublingual | 67046-996 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID ACETATE
buprenorphine drug variants containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CITRIC ACID ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
buprenorphine drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
Excipient focus: CORN SYRUP
buprenorphine drug variants containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
buprenorphine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
buprenorphine drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE
buprenorphine drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| American Regent Inc | buprenorphine hydrochloride | 0517-0725 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBASIC POTASSIUM PHOSPHATE
buprenorphine drug variants containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing DIBASIC POTASSIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
buprenorphine drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | buprenorphine and naloxone | 31722-479 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYL LEVULINATE
buprenorphine drug variants containing ETHYL LEVULINATE
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| Lake Erie Medical DBA Quality Care Products LLC | buprenorphine | 55700-579 |
| Knoa Pharma LLC | buprenorphine | 59011-751 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ETHYL LEVULINATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
buprenorphine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Aveva Drug Delivery Systems Inc | buprenorphine and naloxone | 3215-6521 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
buprenorphine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
buprenorphine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Clinical Solutions Wholesale LLC | buprenorphine | 58118-3156 |
| REMEDYREPACK INC | buprenorphine | 70518-1625 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
buprenorphine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
buprenorphine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL DIOLEATE
buprenorphine drug variants containing GLYCERYL DIOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing GLYCERYL DIOLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
buprenorphine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine hydrochloride | 0143-9246 |
| Hospira Inc | buprenorphine hydrochloride | 0409-2012 |
| American Regent Inc | buprenorphine hydrochloride | 0517-0725 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
buprenorphine drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
buprenorphine drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL METHYLCELLULOSE
buprenorphine drug variants containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | buprenorphine and naloxone | 31722-479 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing HYDROXYPROPYL METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
buprenorphine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
buprenorphine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| Indivior Inc | buprenorphine hydrochloride, naloxone hydrochloride | 0781-7216 |
| INDIVIOR INC | buprenorphine hydrochloride, naloxone hydrochloride | 12496-1202 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
buprenorphine drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
buprenorphine drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| bryant ranch prepack | buprenorphine hydrochloride | 63629-4092 |
| Physicians Total Care Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54868-5750 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
buprenorphine drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
buprenorphine drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Braeburn Inc | buprenorphine | 58284-208 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: LEVULINIC ACID
buprenorphine drug variants containing LEVULINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| Alvogen Inc | buprenorphine | 47781-406 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing LEVULINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
buprenorphine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTITOL
buprenorphine drug variants containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Indivior Inc | buprenorphine hydrochloride, naloxone hydrochloride | 0781-7216 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
buprenorphine drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Rhodes Pharmaceuticals LP | buprenorphine and naloxone | 42858-601 |
| American Health Packaging | buprenorphine and naloxone | 60687-626 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-9482 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
buprenorphine drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| >Company | >Ingredient | >NDC |
Excipient focus: MENTHOL
buprenorphine drug variants containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
buprenorphine drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPYRROLIDONE
buprenorphine drug variants containing METHYLPYRROLIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing METHYLPYRROLIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: OLEYL OLEATE
buprenorphine drug variants containing OLEYL OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| Rhodes Pharmaceuticals LP | buprenorphine | 42858-750 |
| Alvogen Inc | buprenorphine | 47781-406 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing OLEYL OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT OIL
buprenorphine drug variants containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine hydrochloride | 59385-021 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing PEPPERMINT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLY(DL-LACTIC-CO-GLYCOLIC ACID)
buprenorphine drug variants containing POLY(DL-LACTIC-CO-GLYCOLIC ACID)
| Company | Ingredient | NDC |
|---|---|---|
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLY(DL-LACTIC-CO-GLYCOLIC ACID)
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYCARBOPHIL
buprenorphine drug variants containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
buprenorphine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | buprenorphine and naloxone | 31722-479 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
buprenorphine drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Redpharm drug | buprenorphine and naloxone | 67296-1877 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
buprenorphine drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | buprenorphine and naloxone | 63629-4028 |
| Aidarex Pharmaceuticals LLC | buprenorphine hydrochloride, naloxone hydrochloride | 53217-328 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 100000
buprenorphine drug variants containing POLYETHYLENE OXIDE 100000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Camber Pharmaceuticals Inc | buprenorphine and naloxone | 31722-479 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 100000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 1000000
buprenorphine drug variants containing POLYETHYLENE OXIDE 1000000
| Company | Ingredient | NDC |
|---|---|---|
| Aveva Drug Delivery Systems Inc | buprenorphine and naloxone | 3215-6521 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-397 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 1000000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 200000
buprenorphine drug variants containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 200000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 2000000
buprenorphine drug variants containing POLYETHYLENE OXIDE 2000000
| Company | Ingredient | NDC |
|---|---|---|
| Aveva Drug Delivery Systems Inc | buprenorphine and naloxone | 3215-6521 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-397 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 2000000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE OXIDE 900000
buprenorphine drug variants containing POLYETHYLENE OXIDE 900000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Aveva Drug Delivery Systems Inc | buprenorphine and naloxone | 3215-6521 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POLYETHYLENE OXIDE 900000
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
buprenorphine drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| Redpharm Drug | buprenorphine and naloxone | 67296-1933 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
buprenorphine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K29/32
buprenorphine drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
buprenorphine drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
buprenorphine drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine | 47781-406 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
buprenorphine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| Almatica Pharma Inc | buprenorphine and naloxone | 52427-692 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
buprenorphine drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
buprenorphine drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
buprenorphine drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Aveva Drug Delivery Systems Inc | buprenorphine and naloxone | 3215-6521 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
buprenorphine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | buprenorphine and naloxone | 62175-452 |
| REMEDYREPACK INC | buprenorphine and naloxone | 70518-2311 |
| Bryant Ranch Prepack | buprenorphine and naloxone | 71335-1296 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
buprenorphine drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
buprenorphine drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| AvPAK | buprenorphine | 50268-128 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
buprenorphine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
buprenorphine drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Aveva Drug Delivery Systems Inc | buprenorphine and naloxone | 3215-6521 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-364 |
| INGENUS PHARMACEUTICALS LLC | buprenorphine and naloxone | 50742-397 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
buprenorphine drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-579 |
| DrReddys Laboratories Inc | buprenorphine and naloxone | 43598-580 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
buprenorphine drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| Quality Care Products LLC | buprenorphine hydrochloride | 55700-867 |
| BioDelivery Sciences International Inc | buprenorphine and naloxone | 59385-012 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
buprenorphine drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | buprenorphine hcl | 0406-7012 |
| PAI Holdings LLC dba Pharmaceutical Associates Inc and dba PAI Pharma | buprenorphine hydrochloride | 0121-1019 |
| A-S Medication Solutions | buprenorphine hydrochloride | 50090-1571 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
buprenorphine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Indivior Inc | buprenorphine | 12496-0100 |
| Aveva Drug Delivery Systems Inc | buprenorphine | 3215-1521 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
buprenorphine drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine and naloxone | 0228-3154 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
buprenorphine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8765 |
| Mylan Pharmaceuticals Inc | buprenorphine and naloxone | 0378-8767 |
| Alvogen Inc | buprenorphine and naloxone | 47781-355 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
buprenorphine drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-0002 |
| Correct Rx Pharmacy Services Inc | buprenorphine | 24555-2222 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
buprenorphine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Major Pharmaceuticals | buprenorphine | 0904-7154 |
| Alvogen Inc | buprenorphine buccal | 47781-471 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| Indivior Inc | buprenorphine | 12496-0100 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZEA MAYS
buprenorphine drug variants containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | buprenorphine hydrochloride | 50090-1571 |
| >Company | >Ingredient | >NDC |
buprenorphine drug variants not containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | buprenorphine | 0054-0176 |
| Teva Pharmaceuticals USA Inc | buprenorphine | 0093-3656 |
| Actavis Pharma Inc | buprenorphine | 0228-3156 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
